Joel Schlessinger, MD

Advanced Skin Research Center
Omaha, NE
USA 68144
Papers:
A Multicenter, Randomized, Double-Blind Phase 2B Study of ATX-101 in the Reduction of Submental Fat Using Investigator, Subject, and Magnetic Resonance Imaging Assessments
Long-Term Safety of Abobotulinumtoxin A for the Treatment of Glabellar Lines From a 36-Month, Multicenter, Open-Label Extension Study